Clinical trial
Krypton-Argon Regression of Neovascularization Study (KARNS)
NCT00000153 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00000153 |
|---|---|
| Title | Krypton-Argon Regression of Neovascularization Study (KARNS) |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy, Retinal Neovascularization, Diabetes Mellitus |
| Intervention type | Procedure |
| Interventions | Blue-Green Argon Laser Treatment, Red Krypton Laser Treatment |
| Start date | Dec 1, 1984 |
| First posted | Sep 24, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: